Eskandari Mark K, Resnick Scott A
Division of Vascular Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL 60613, USA.
Semin Vasc Surg. 2005 Dec;18(4):202-8. doi: 10.1053/j.semvascsurg.2005.09.006.
Increasing utilization of diagnostic imaging studies has provided newer insight into our current knowledge of visceral artery aneurysms. Because many are "silent," an appreciation of the true incidence and natural history of these nonaortic arterial aneurysms is only recently being understood. Historical data suggest that renal artery aneurysms (RAAs) occur in approximately 0.1% of the general population. Recognized complications associated with RAAs include renovascular hypertension, renal artery thrombosis, infarction from distal embolization, arteriovenous fistula formation, and, the most dreaded risk, rupture. Unfortunately, there remains continued controversy about the indications for and mode of treating RAAs. This article attempts to shed some light on the contemporary management options in view of advances in percutaneous endoluminal interventions.
诊断性影像学检查的使用日益增加,为我们当前对内脏动脉瘤的认识提供了新的见解。由于许多内脏动脉瘤是“无症状的”,人们直到最近才开始了解这些非主动脉动脉动脉瘤的真实发病率和自然病程。历史数据表明,肾动脉瘤(RAA)在普通人群中的发生率约为0.1%。与RAA相关的公认并发症包括肾血管性高血压、肾动脉血栓形成、远端栓塞引起的梗死、动静脉瘘形成,以及最可怕的风险——破裂。不幸的是,关于RAA的治疗指征和治疗方式仍存在持续的争议。鉴于经皮腔内介入治疗的进展,本文试图阐明当代的管理选择。